Brokerages Set Olin Corporation (NYSE:OLN) PT at $24.71

Shares of Olin Corporation (NYSE:OLNGet Free Report) have received a consensus rating of “Hold” from the sixteen research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating, two have given a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $24.0714.

A number of equities analysts have recently commented on OLN shares. Wall Street Zen downgraded Olin from a “hold” rating to a “sell” rating in a report on Saturday. Citigroup dropped their target price on shares of Olin from $23.00 to $21.00 and set a “neutral” rating for the company in a research report on Thursday, December 18th. Fermium Researc raised shares of Olin to a “strong-buy” rating in a research report on Thursday, September 25th. UBS Group decreased their price objective on shares of Olin from $24.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, October 29th. Finally, Royal Bank Of Canada set a $26.00 price objective on shares of Olin and gave the stock a “sector perform” rating in a research report on Tuesday, October 14th.

Check Out Our Latest Research Report on OLN

Trending Headlines about Olin

Here are the key news stories impacting Olin this week:

Olin Stock Performance

NYSE:OLN opened at $23.89 on Thursday. The company has a market cap of $2.73 billion, a P/E ratio of 51.94, a P/E/G ratio of 2.08 and a beta of 1.64. The firm’s 50 day moving average is $20.61 and its two-hundred day moving average is $21.85. Olin has a fifty-two week low of $17.66 and a fifty-two week high of $34.76. The company has a quick ratio of 0.89, a current ratio of 1.56 and a debt-to-equity ratio of 1.49.

Olin (NYSE:OLNGet Free Report) last released its quarterly earnings data on Monday, October 27th. The specialty chemicals company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.31. Olin had a return on equity of 3.36% and a net margin of 0.79%.The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the firm posted ($0.21) EPS. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. Analysts expect that Olin will post 1.38 EPS for the current year.

Olin Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Friday, November 28th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 3.3%. The ex-dividend date was Friday, November 28th. Olin’s dividend payout ratio is currently 173.91%.

Insider Activity at Olin

In other news, VP Teresa M. Vermillion sold 4,500 shares of the company’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $20.86, for a total value of $93,870.00. Following the completion of the sale, the vice president owned 17,199 shares of the company’s stock, valued at $358,771.14. This represents a 20.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Olin

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Strategic Advocates LLC acquired a new stake in Olin in the third quarter valued at approximately $25,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in shares of Olin in the first quarter valued at $32,000. Bessemer Group Inc. grew its holdings in Olin by 712.7% during the 3rd quarter. Bessemer Group Inc. now owns 1,341 shares of the specialty chemicals company’s stock valued at $34,000 after purchasing an additional 1,176 shares in the last quarter. Evelyn Partners Investment Management LLP grew its holdings in Olin by 6,360.0% during the 2nd quarter. Evelyn Partners Investment Management LLP now owns 1,615 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 1,590 shares in the last quarter. Finally, UMB Bank n.a. increased its stake in Olin by 134.9% during the 2nd quarter. UMB Bank n.a. now owns 1,736 shares of the specialty chemicals company’s stock worth $35,000 after buying an additional 997 shares during the period. 88.67% of the stock is owned by institutional investors and hedge funds.

Olin Company Profile

(Get Free Report)

Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.

In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.

Featured Articles

Analyst Recommendations for Olin (NYSE:OLN)

Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.